Filed numbers, not market-size rhetoric

Growing sales at micro-enterprise scale.

Atlas’s filings show real commercial activity and a materially better 2024. They also show an early company that relied on financing income in 2022–2023, has substantial receivables, and discloses no customers, product mix or export volume.

Four years of filed financials

All amounts are BGN thousands and refer to Atlas Agro Science as a company, not to an individual product or distributor channel.

YearNet salesFinancing incomeTotal incomeExpensesAfter-tax resultAssetsEquity
20216067−15411
2022644611046587369
2023149123272296−246345
2024247024716376165121

Positive signal

2024 stands apart

It is the first filed year showing both the highest sales and a profit without financing income in the income statement.

Filed accounts

Quality of earnings

Earlier profits need context

Financing supplied 42% of 2022 total income. In 2023 it supplied 45%, yet the company still recorded a loss.

Filed accounts

Working capital

Receivables are material

2024 receivables were BGN 126k—about 51% of annual sales—against BGN 24k cash.

Balance sheet

How the business was funded

The public record supports a mix of founder support, innovation-program awards, grant activity and trading revenue. It does not provide a complete funding ledger.

Distribution is affiliated, but legally separate

Atlas presents ATC Agro Finance as its exclusive sales channel and “part of the structure.” Registry records do not show it as an Atlas subsidiary.

What is public

ATC Agro Finance · UIC 206519096

Founded May 2021. Manager: Ivaylo Petrov Minkov. Owners: All Tax Consulting 60% and Ivaylo Petrov Minkov 40%.

Separate entity

What is not public

Commercial terms

The exclusivity agreement, transfer pricing, commissions, inventory ownership, receivables split and any related-party economics were not found.

Contract needed

Shared surnames may suggest personal connections. This dossier does not infer family relationships without authoritative evidence.

Germany: commercially plausible, not investment-ready

A separate market-entry assessment tests a prospective German distribution business against legal routes, real competitors, farm economics and channel margins.

Category correction

Current Terra is not documented as sludge-derived

The present product orders list molasses and leonardite. The direct comparison is the biostimulant market, not bulk sewage sludge.

Orders checked

Territory

No public German holder identified

Public research found no German or Holland-based appointee, but private contracts and reservations cannot be excluded.

Authority required

Farmer price

Competitive at low-to-medium rates

Modelled Terra treatment cost of €11–€33/ha sits inside the observed German biostimulant range.

Scenario

Distributor margin

Public wholesale prices fail

At the visible 1,000+ L prices, direct gross margin is only about 10–16% under the base model and dealer sales lose money.

Renegotiate

Recommended structure: Germany-only conditional exclusivity, no standalone rights fee, small original-pack pilot, and source-price targets near €5.30/L Terra, €6.40/L Nitro and €6.90/L Amino under the stated model.

Read the complete Germany market-entry and unit-economics assessment →

Published offer at the cutoff

ATC advertised product plus agronomic support, analysis, drone application, financing and insurance-style services. Published availability is a webpage state, not proof of factory shutdown.

Product5 L retail
VAT included
20 L tier
per L, ex VAT
1,000+ L tier
per L, ex VAT
Direct page status
Atlas TerraEUR 72.90EUR 10.74EUR 8.69Out of stock
Atlas Terra NitroEUR 82.20EUR 12.27EUR 10.23Out of stock
Atlas Terra AminoEUR 91.20EUR 13.80EUR 11.76Out of stock

Observed 30 August 2026. “Out of stock” could reflect inventory, ecommerce administration or channel strategy. Public evidence does not resolve which.

Market context without pretending it is market share

Atlas’s strategy targets 10% of a domestic market but does not define the denominator or date. A broad official expenditure category illustrates the distance between aspiration and current scale.

BGN 950.1m2024 Bulgarian expenditure on fertilizer and soil improvers—a broad category, not Atlas’s addressable market
0.026%Atlas 2024 sales divided by that broad category; an orientation ratio, not a measured market share
~385×Scale-up from BGN 247k sales to a hypothetical BGN 95m, if 10% referred to the broad category

Do not quote the 0.026% as Atlas’s actual market share. The denominator includes categories and suppliers outside the company’s disclosed target. The calculation only makes the strategy’s undefined “10%” concrete enough to interrogate.

Traction: what is real and what is still unquantified

Public visibility is evidence of activity. It is not automatically evidence of contracted revenue or repeat demand.

Supported activity

  • Filed sales rising through 2024.
  • Municipal product use in several landscaping settings.
  • Trade-fair, accelerator and innovation-program participation.
  • Distributor catalogue, tiered prices and service packages.
  • 2026 general-brand partnership with the Hristo Stoichkov initiative.

Commercial proof still missing

  • Customer names, contracts, order book and retention.
  • Product-level revenue, units, margin and channel mix.
  • Exports and geographic sales split.
  • Paid versus donated municipal volume.
  • Current inventory, output, backlog and on-time delivery.
  • Receivables aging and collection after year-end.

The Atlas-issued “Green Certificate” is a marketing recognition, not a regulator or independent environmental certification. Recipient municipal pages confirm some relationships; at least some product was explicitly donated, so revenue cannot be inferred.